Skip to main content
. 2020 Apr 14;11(4):230. doi: 10.1038/s41419-020-2381-8

Fig. 7. MOB2 binds to PKA and enhances PKA activity.

Fig. 7

a LN-229 and T98G cells with a stable knockdown of MOB2 or control cells were treated with vehicle (DMSO) or Forskolin (FSK), IB analysis for p-CREB, CREB and MOB2, GAPDH was used as a loading control. b SF-539 and SF-767 cells with stable overexpression of MOB2 or control cells were treated with vehicle (DMSO) or SQ22536, IB analysis for p-CREB, CREB and MOB2, GAPDH was used as a loading control. c LN-229 and T98G whole-cell lysates (WCL) collected from 10 cm2 dishes were subjected to immunoprecipitation (IP) with an anti-MOB2 antibody or an IgG control. d, e 293T cells transfected with GFP-tagged PKA (GFP-PKA) and V5-tagged MOB2 (V5-MOB2). Cell lysates were subjected to immunoprecipitation (IP) with anti-GFP (d) or anti-V5 antibody (e) and immunoblotted (IB) with the indicated antibodies. f Hs683, LN-18 and U87MG cells were treated with vehicle (DMSO) or Forskolin (FSK), IB analysis for MOB1 and MOB2, GAPDH was used as a loading control. g LN-229 and T98G cells were treated with vehicle (DMSO) or H89, IB analysis for MOB1 and MOB2, GAPDH was used as a loading control. All experiments in this figure were performed as three independent experiments.